Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Debt / NOTE 3.000%12/0
-
Market price (% of par)
-
108.12%
-
Total 13F principal
-
$68,463,453
-
Principal change
-
-$6,108,927
-
Total reported market value
-
$74,046,410
-
Number of holders
-
23
-
Value change
-
-$4,775,084
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 as of Q2 2016
As of 30 Jun 2016,
ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 was held by
23 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$68,463,453
in principal (par value) of the bond.
The largest 10 bondholders included
FMR LLC, WOLVERINE ASSET MANAGEMENT LLC, GUARDIAN LIFE INSURANCE CO OF AMERICA, PERCEPTIVE ADVISORS LLC, Allianz Asset Management AG, CITADEL ADVISORS LLC, OAKTREE CAPITAL MANAGEMENT LP, Bank of New York Mellon Corp, GABELLI FUNDS LLC, and DEUTSCHE BANK AG\.
This page lists
23
institutional bondholders reporting positions
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.